Article
677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
Pharmacogenomics - 1 Nov 2007
Kurzawski Mateusz, Pawlik Andrzej, Safranow Krzysztof, Herczynska Magdalena, Drozdzik Marek
Abstract excerpt
INTRODUCTION: Methotrexate (MTX), widely used in the treatment of rheumatoid arthritis (RA), inhibits dihydrofolate reductase and folate-dependent enzymes. Methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism and has been shown to be polymorphic, affecting the enzyme activity. METHODS: To examine the association between 677C>T and 1298A>C MTHFR polymorphisms and MTX efficacy in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
